Sales Agreements in the Life Sciences Tools & Services Industry
12 Contracts & Agreements
- AbSci Corp (1 contract)
- ARYA Sciences Acquisition Corp III (1)
- BioNano Genomics, Inc (2)
- ChromaDex Corp. (1)
- Mettler Toledo (2)
- NanoString Technologies Inc (2)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (2)
- Personalis, Inc. (1)
- Sales Agreement, dated as of February 28, 2024, between Nautilus Biotechnology, Inc. and Cowen and Company, LLC (ARYA Sciences Acquisition Corp III, Filed With SEC on February 28, 2024)
- Sales Agreement, dated June 16, 2023, by and between Absci Corporation and Cowen and Company, LLC (AbSci Corp, Filed With SEC on June 16, 2023)
- Amendment No. 1 to Sales Agreement, dated March 9, 2023, by and between the Company and Cowen and Company, LLC (BioNano Genomics, Inc, Filed With SEC on May 9, 2023)
- At-the-Market Sales Agreement, dated December 30, 2021, by and between Personalis, Inc. and BTIG, LLC (Personalis, Inc., Filed With SEC on January 3, 2022)
- Sales Agreement, dated March 23, 2021, by and between the Company and Cowen and Company, LLC (BioNano Genomics, Inc, Filed With SEC on March 24, 2021)
- Sales Agreement, dated as of December 20, 2017, between NanoString Technologies, Inc. and Cowen and Company, LLC (NanoString Technologies Inc, Filed With SEC on January 8, 2018)
- NANOSTRING TECHNOLOGIES, INC. $40,000,000 COMMONSTOCK SALES AGREEMENT (NanoString Technologies Inc, Filed With SEC on May 12, 2015)
- Pacific Biosciences of California, Inc. Controlled Equity OfferingSM Amendment No. 2 to Sales Agreement (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on February 3, 2015)
- PACIFIC BIOSCIENCES OF CALIFORNIA, INC. CONTROLLED EQUITY OFFERINGSM AMENDMENT NO. 1 TO SALES AGREEMENT (PACIFIC BIOSCIENCES OF CALIFORNIA, INC., Filed With SEC on November 12, 2013)
- CHROMADEX INC. SALES CONFIRMATION AND CONTRACT (ChromaDex Corp., Filed With SEC on March 29, 2013)
- A Group targets: Group EPS, NCO, ITO, Sales and Divisional Sales, EBIT B Operative unit targets: Operative Units Sales, EBIT, ITO and DSO C Personal targets: 10 15%; for the CFO... (Mettler Toledo, Filed With SEC on February 13, 2009)
- A Group targets Group EPS, NCO, ITO, Sales and Divisional Sales,EBIT B Operative unit targets Operative Units Sales, EBIT, ITO, DSO C Personal targets 10%; for Finance Control... (Mettler Toledo, Filed With SEC on February 13, 2009)